Ocular hypertension following intravitreal injection of 0.7mg dexamethasone implant versus 2mg triamcinolone

被引：0
|
作者：
Kuley, Brandon [1 ]
Storey, Philip [2 ]
Pancholy, Maitri [1 ]
Obeid, Anthony [2 ]
Murphy, James [1 ]
Goodman, Jake [1 ]
Wibbelsman, Turner D. [2 ]
Regillo, Carl [2 ]
Chiang, Allen [2 ]
机构：
[1] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA
[2] Wills Eye Hosp & Res Inst, Retina, Philadelphia, PA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2645
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Randomized Controlled Trial Comparing the Effects on Eye Pressure of Intravitreal Triamcinolone Injection versus Intravitreal Dexamethasone (Ozurdex) Implant in Patients with Diabetic Macular Edema TRIDEX TRIAL
    Medeiros Fulco, Enzo Augusto
    Junqueira, Natacha Biscaro
    Messias, Andre
    Jorge, Rodrigo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [42] Radiation Macular Edema after Ru-106 Plaque Brachytherapy for Choroidal Melanoma Resolved by an Intravitreal Dexamethasone 0.7-mg Implant
    Russo, Andrea
    Avitabile, Teresio
    Uva, Maurizio
    Faro, Salvatore
    Franco, Livio
    Sanfilippo, Marisa
    Gulisano, Seby
    Toro, Mario
    De Grande, Vittorio
    Rametta, Stefania
    Foti, Laura
    Longo, Antonio
    Reibaldi, Michele
    CASE REPORTS IN OPHTHALMOLOGY, 2012, 3 (01): : 71 - 76
  • [43] Efficacy and Safety of 0.5 mg Ranibizumab compared with 0.7 mg dexamethasone intravitreal implant in patients with branch retinal vein occlusion over 6 months: The COMRADE-B study
    Hattenbach, Lars-Olof
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [44] Secondary Glaucoma After Intravitreal Dexamethasone 0.7 mg Implant in Patients with Retinal Vein Occlusion: A One-Year Follow-Up
    Meyer, Linda M.
    Schoenfeld, Carl-Ludwig
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 29 (06) : 560 - 565
  • [45] Efficacy and Safety of 0.5 mg Ranibizumab Administered as Intravitreal Injections PRN Compared with Intravitreal Implant Containing 0.7 mg Dexamethasone in Patients with Branch Retinal Vein Occlusion Over 6 Months: The COMRADE-B Study
    Hattenbach, Lars-Olof
    Hoerauf, Hans
    Feltgen, Nicolas
    Lang, Gabrielle
    Taylor, Simon
    Schmitz-Valckenberg, Steffen
    Wolf, Armin
    Knorr, Thomas
    OPHTHALMOLOGICA, 2014, 232 : 90 - 90
  • [46] Efficacy and Safety of 0.5 mg Ranibizumab Compared with Intravitreal Implant Containing 0.7 mg Dexamethasone in Patients with Central Retinal Vein Occlusion Over 6 Months: The COMRADE-C Study
    Hoerauf, Hans
    Feltgen, Nicolas
    Eter, Nicole
    Hattenbach, Lars-Olof
    Rehak, Matus
    Pankaj, Puri
    Berk, Huesnue
    Knorr, Thomas
    OPHTHALMOLOGICA, 2014, 232 : 90 - 90
  • [47] Safety and efficacy of ranibizumab 0.5 mg vs dexamethasone 0.7 mg intravitreal implant in patients with branch or central retinal vein occlusion: long-term results of the COMRADE -Extension study
    Feltgen, Nicolas
    Bertelmann, Thomas
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [48] Additional visual and anatomic outcomes of intravitreal aflibercept injection 8 mg versus 2 mg: a post hoc analysis of the Phase 2 CANDELA study
    Fein, Jordana Goren
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [49] Morfo-Functional Aspects of a Case of Relapsing Bilateral Acute Retinal Pigment Epithelitis (ARPE) and Effects of Treatment Using Dexamethasone 0.7 mg Intravitreal Implant
    Magliozzi, Patrizio
    Ambrosio, Gennaro
    Ambrosio, Lucia
    OPHTHALMOLOGICA, 2014, 232 : 59 - 59
  • [50] Efficacy of subtenon 20-mg triamcinolone injection versus 0.1% dexamethasone eye drops for controlling inflammation after phacoemulsification: a randomized controlled trial
    Pitipol Choopong
    Nuttacha Taetrongchit
    Sutasinee Boonsopon
    Atchariya Nimkarn
    Kanyapak Srisukkosalin
    Pratuangsri Chonpimai
    Waree Nujoi
    Krissana Maneephagaphun
    Noppakhun Panyayingyong
    Nattaporn Tesavibul
    Scientific Reports, 12
12345